I’m looking for education in
Clinical Topic
Monograph
2.25
ACPE
Pharmacist-Led PEP/PrEP
1.00 AMA PRA
Chronic Rhinosinusitis with Nasal Polyps
0.75 CME/ANCC
The Top 10 Pitfalls in Initiating Advanced Therapy in IBD
1.00 CME/ANCC
Not A Moment Too Soon
Webcast
1.00 CME/CE
Lifting the Burdens of Idiopathic Hypersomnia
Webcast Series
1.00
AMA PRA
ASCVD Clinical Research Updates
Webcast
0.50 AMA PRA
Oncology News: nccRCC Edition
Webcast Series
1.00
AMA PRA
Making The Call in Lower-Risk MDS
Monograph
2.25 ACPE
Pharmacist-Led PEP/PrEP
| Course 1: | Pharmacist-Led PEP/PrEP |
| Course 2: | Test Your Skills |
1.00 AMA PRA
Chronic Rhinosinusitis with Nasal Polyps
Navigating New Pathways to Better Patient Outcomes
| Faculty: | Flavia Hoyte, MD; Stella Lee, MD |
| Release: | 09/19/2024 |
| Expiration: | 09/19/2025 |
0.75 CME/ANCC
The Top 10 Pitfalls in Initiating Advanced Therapy in IBD
Tools to Optimize Patient Outcomes
| Faculty: | Bruce E. Sands, MD, MS |
| Release: | 09/18/2024 |
| Expiration: | 09/18/2025 |
1.00 CME/ANCC
Not A Moment Too Soon
Incorporating Multi-Cancer Early Detection (MCED) Testing Into Primary Care Practice
| Faculty: | Richard A. Whittington, MD |
| Release: | 09/12/2024 |
| Expiration: | 09/12/2025 |
Webcast
1.00 CME/CE
Lifting the Burdens of Idiopathic Hypersomnia
Accelerating Diagnosis and Individualizing Management
| Faculty: | Richard K. Bogan, MD, FCCP, FAASM; Karl Doghramji, MD, FAASM, DFAPA |
| Release: | 09/09/2024 |
| Expiration: | 09/09/2025 |
Webcast Series
1.00 AMA PRA
ASCVD Clinical Research Updates
| Course 1: | Exploring the Link Between Systemic Inflammation, Atherosclerosis, and CKD |
| Course 2: | Management of ASCVD in Patients with CKD: Present, Past, and Future |
Webcast
0.50 AMA PRA
Oncology News: nccRCC Edition
A Tailored Approach: Evidence-Based Management Strategies for Advanced/Metastatic ncc-RCC
| Faculty: | Sumanta K. Pal, MD, FASCO; Wesley Yip, MD |
| Release: | 08/28/2024 |
| Expiration: | 08/28/2025 |
Webcast Series
1.00 AMA PRA
Making The Call in Lower-Risk MDS
| Course 1: | Management of newly diagnosed, treatment-naive LR-MDS |
| Course 2: | Management of erythropoiesis-stimulating agent (ESA)-refractory, LR-MDS with RS |
| Course 3: | Management of treatment-naïve LR-MDS |
| Course 4: | Individualized 1L Therapeutic Decision-Making in LR-MDS with Del5Q |
